Refractory Cachexia
Refractory Cachexia is a clinical syndrome characterized by irreversible weight loss and muscle wasting that persists despite optimal treatment of the underlying disease and targeted nutritional or pharmacological interventions.
22
Publications
934
Citations
141
Authors
70
Institutions
Publications per year
2017–2026
12
Parents
22
Thalidomide in patients with cachexia due to terminal cancer: Preliminary report
Éduardo Bruera, Catherine M. Neumann, Edith Pituskin et al. · Annals of Oncology · 1999 · 128 citations · Full text
Barbara S. van der Meij, Coline P. Schoonbeek, Egbert F. Smit et al. · British Journal Of Nutrition · 2012 · 65 citations · Full text
Medicine, Oncology, Chemotherapy +14
1–5 of 22
141
2
h-index
2
h-index
1
h-index
1
h-index
1
h-index
1–5 of 141
70
Charité - Universitätsmedizin Berlin
Berlin, Germany
4 h-index
9 publications
343 citations

University of Alberta
Edmonton, Canada
3 h-index
8 publications
1K citations
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
2 h-index
10 publications
142 citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
2 h-index
9 publications
308 citations

Rhode Island Hospital
Providence, United States
1 h-index
1 publications
74 citations
University of California, Los Angeles
Los Angeles, United States
1 h-index
1 publications
61 citations

Juntendo University
Tokyo, Japan
1 h-index
11 publications
286 citations

Sapienza University of Rome
Rome, Italy
1 h-index
1 publications
65 citations
1–8 of 70
5 publications · 214 citations
5
h-index
2 publications · 52 citations
2
h-index
1 publications · 128 citations
1
h-index
Repository · 1 publications · 17 citations
1
h-index
BJN · 1 publications · 65 citations
1
h-index
1–5